CAS: 1092578-47-6; 3-((3S,4S)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanenitrile

该化合物是其复杂的分子结构结构,包括一个管状环,一种丙烯-丙酰胺和一种硝基苯基苯基苯的功能组,该化合物由于潜在的药效特性,包括同生物目标的相互作用,往往对药用化学化学特性感兴趣.

结构式图片

上下游产品

N-methyl-N-((3S,4S)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine cyanoacetic acid

合成工艺路线路线简述

    N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine,氰乙酸置于n,N-二异丙基乙胺,Methanaminium,N-[(Dimethylamino)(3H-1,2,3-Triazolo[4,5-B]Pyridin-3-Yloxy)Methylene]-N-Methyl-,Hexafluorophosphate(1-)体系中,用 N,N-二甲基甲酰胺 用作溶剂,化学反应 0.5H,反应生成(3S,4S)-4-甲基-3-(甲基-7H-吡咯并[2,3-D]嘧啶-4-氨基)-Beta-氧代-1-哌啶丙腈
    参考文献:Examining The Chirality,Conformation And Selective Kinase Inhibition Of 3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanenitrile (Cp-690,550)
    标题:Examining The Chirality,Conformation And Selective Kinase Inhibition Of 3-((3R,4R)-4-Methyl-3-(Methyl(7H-Pyrrolo[2,3-D]Pyrimidin-4-yl)Amino)Piperidin-1-yl)-3-Oxopropanenitrile (Cp-690,550)
    摘要:Here,We Examine The Significance That Stereochemistry Plays Within The Clinically Relevant Janus Kinase 3 (Jak3) Inhibitor 1 (Cp-690,550). A Synthesis Of All Four Enantiopure Stereoisomers Of The Drug Was Carried Out And An Examination Of Each Compound Revealed That Only The Enantiopure 3R,4R Isomer Was Capable Of Blocking Stat5 Phosphorylation (Jak3 Dependent). Each Compound Was Profiled Across A Panel Of Over 350 Kinases,Which Revealed A High Level Of Selectivity For The Jak Family Kinases For These Related Compounds. Each Stereoisomer Retained A Degree Of Binding To Jak3 And Jak2 And The 3R,4S And 3S,4R Stereoisomers Were Further Revealed To Have Binding Affinity For Selected Members Of The Ste7 And Ste20 Subfamily Of Kinases. Finally,An Appraisal Of The Minimum Energy Conformation Of Each Stereoisomer And Molecular Docking At Jak3 Was Performed In An Effort To Better Understand Each Compounds Selectivity And Potency Profiles.
    Doi:10.1021/jm801142B

    海关参考信息

    珠海优润医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.zhyourun.com/
    电话: 0756-6811852👤
    📞珠海优润医药科技有限公司 ⚠️参考联系方式

    销售电话:0756-6811852
    邮箱:zhyrpharm_sales03@126.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1021/jm801142b
    摘要:Jiang J, Ghoreschi K, Deflorian F, Chen Z, Perreira M, Pesu M, Smith J, Nguyen D, Liu EH, Leister W, Costanzi S, O’Shea JJ, Thomas CJ. Examining the Chirality, Conformation and Selective Kinase Inhibition of 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile (CP-690,550). J. Med. Chem. 2008 Nov 19;51(24):8012–8. doi: 10.1021/jm801142b.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知